|
RASA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.008000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.445200E-01 |
| Normal-vs-Stage2 |
7.338200E-01 |
| Normal-vs-Stage3 |
2.727000E-01 |
| Normal-vs-Stage4 |
5.785600E-01 |
| Stage1-vs-Stage2 |
6.957400E-01 |
| Stage1-vs-Stage3 |
2.424300E-02 |
| Stage1-vs-Stage4 |
1.290580E-01 |
| Stage2-vs-Stage3 |
2.548800E-01 |
| Stage2-vs-Stage4 |
4.715000E-01 |
| Stage3-vs-Stage4 |
7.301400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.576800E-01 |
| Normal-vs-AfricanAmerican |
7.637200E-01 |
| Normal-vs-Asian |
2.862000E-01 |
| Caucasian-vs-AfricanAmerican |
6.732000E-01 |
| Caucasian-vs-Asian |
1.017010E-01 |
| AfricanAmerican-vs-Asian |
2.630000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.955800E-01 |
| Normal-vs-Female |
3.187600E-01 |
| Male-vs-Female |
1.474990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.268600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.958800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.485200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.092200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.159000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.470200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.410000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.089600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.448200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.649000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.149800E-02 |
| Normal-vs-Grade 2 |
1.275020E-01 |
| Normal-vs-Grade 3 |
3.113400E-01 |
| Normal-vs-Grade 4 |
4.224000E-01 |
| Grade 1-vs-Grade 2 |
1.342830E-01 |
| Grade 1-vs-Grade 3 |
5.780400E-03 |
| Grade 1-vs-Grade 4 |
4.655900E-02 |
| Grade 2-vs-Grade 3 |
4.844200E-03 |
| Grade 2-vs-Grade 4 |
6.868300E-02 |
| Grade 3-vs-Grade 4 |
8.484800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.305600E-02 |
| Normal-vs-ccB subtype |
4.993600E-01 |
| ccA subtype-vs-ccB subtype |
7.497200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.877400E-01 |
| Normal-vs-N1 |
8.129200E-01 |
| N0-vs-N1 |
5.773000E-01 |
|
|
